Limits...
Diagnosing Psoriatic Arthritis from the Dermatologist's View.

Cho HH, Kim BS - J Lifestyle Med (2013)

Bottom Line: Psoriatic arthritis is a chronic inflammatory arthropathy associated with skin psoriasis.It is considered a unique arthropathy with distinct clinical and radiologic features.Biologic agents, including TNF-α inhibitors and anti-IL12/23 agents, have shown dramatic improvement.

View Article: PubMed Central - PubMed

Affiliation: Department of Dermatology, School of Medicine, Pusan National University Hospital, Busan ; Pusan National University Yangsan Hospital, Yangsan, Korea.

ABSTRACT
Psoriatic arthritis is a chronic inflammatory arthropathy associated with skin psoriasis. It is considered a unique arthropathy with distinct clinical and radiologic features. Up to 40% of patients with psoriasis may develop psoriatic arthritis. Psoriasis usually precedes psoriatic arthritis, so dermatologists are in a critical position for screening patients of psoriatic arthritis early in the disease course. Psoriatic arthritis may be challenging to diagnose, especially for dermatologists, because it has an insidious disease course, non-specific symptoms, and no specific biomarkers. Psoriatic arthritis is a polygenic autoimmune disorder of unknown etiology, but immunologic roles have recently been validated. In recent years, treatment modalities have rapidly advanced in the fields of psoriasis and psoriatic arthritis. Biologic agents, including TNF-α inhibitors and anti-IL12/23 agents, have shown dramatic improvement.

No MeSH data available.


Related in: MedlinePlus

Recommended diagnosis and referral algorithm for psoriatic arthritis.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4390746&req=5

f3-jlm-03-85: Recommended diagnosis and referral algorithm for psoriatic arthritis.

Mentions: Dermatologists can conduct a full screening and confirm PsA in psoriasis patients who are visiting a dermatologic department. When managing PsA, oligo- and DIP arthritis can be managed by dermatologists, whereas polyarthritis, spondylitis, and arthritis multilans should be referred to rheumatologists (Fig. 3).


Diagnosing Psoriatic Arthritis from the Dermatologist's View.

Cho HH, Kim BS - J Lifestyle Med (2013)

Recommended diagnosis and referral algorithm for psoriatic arthritis.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4390746&req=5

f3-jlm-03-85: Recommended diagnosis and referral algorithm for psoriatic arthritis.
Mentions: Dermatologists can conduct a full screening and confirm PsA in psoriasis patients who are visiting a dermatologic department. When managing PsA, oligo- and DIP arthritis can be managed by dermatologists, whereas polyarthritis, spondylitis, and arthritis multilans should be referred to rheumatologists (Fig. 3).

Bottom Line: Psoriatic arthritis is a chronic inflammatory arthropathy associated with skin psoriasis.It is considered a unique arthropathy with distinct clinical and radiologic features.Biologic agents, including TNF-α inhibitors and anti-IL12/23 agents, have shown dramatic improvement.

View Article: PubMed Central - PubMed

Affiliation: Department of Dermatology, School of Medicine, Pusan National University Hospital, Busan ; Pusan National University Yangsan Hospital, Yangsan, Korea.

ABSTRACT
Psoriatic arthritis is a chronic inflammatory arthropathy associated with skin psoriasis. It is considered a unique arthropathy with distinct clinical and radiologic features. Up to 40% of patients with psoriasis may develop psoriatic arthritis. Psoriasis usually precedes psoriatic arthritis, so dermatologists are in a critical position for screening patients of psoriatic arthritis early in the disease course. Psoriatic arthritis may be challenging to diagnose, especially for dermatologists, because it has an insidious disease course, non-specific symptoms, and no specific biomarkers. Psoriatic arthritis is a polygenic autoimmune disorder of unknown etiology, but immunologic roles have recently been validated. In recent years, treatment modalities have rapidly advanced in the fields of psoriasis and psoriatic arthritis. Biologic agents, including TNF-α inhibitors and anti-IL12/23 agents, have shown dramatic improvement.

No MeSH data available.


Related in: MedlinePlus